Evidence map›Paper›PMID 42658242›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2026

Depressive symptom heterogeneity and mortality in a prospective U.S. cohort.

Ze Jin

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ze JinIcahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, 10029, USA. ze.jin@icahn.mssm.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDepressive symptoms are associated with increased mortality, but whether individual symptoms differ in their associations with mortality remains incompletely characterized.

methodsA prospective analysis of U.S. National Health and Nutrition Examination Survey data linked to mortality follow-up through 2019 examined PHQ-9 total score, affective and somatic domains, and individual items in relation to all-cause, heart disease, and non-cardiac mortality using survey-weighted Cox models. Item-level analyses were exploratory and adjusted for multiple comparisons.

resultsAmong 17,935 participants, 885 deaths occurred. Each 1-point increase in PHQ-9 total score was associated with higher all-cause mortality (hazard ratio [HR], 1.036; 95% confidence interval [CI], 1.012-1.061; P=.003). When affective and somatic domains were modeled simultaneously, only the somatic domain remained modestly associated with all-cause mortality (HR, 1.044; 95% CI, 1.003-1.087; P=.037). In separate item analyses, anhedonia (HR, 1.256), fatigue (HR, 1.215), appetite or weight disturbance (HR, 1.175), and thoughts of death or self-harm (HR, 1.477) were associated with all-cause mortality after false discovery rate correction (adjusted P≤.014). In the mutually adjusted model, anhedonia (HR, 1.20), fatigue (HR, 1.21), and thoughts of death or self-harm (HR, 1.51) remained associated. Item-level models improved in-sample fit (likelihood-ratio P=.001) but minimally improved discrimination (ΔC-index=0.001).

conclusionsHigher depressive symptom burden was associated with all-cause mortality. Exploratory analyses suggested symptom-level heterogeneity, but item-level modeling did not meaningfully improve discrimination; symptom-specific findings require independent replication.

Indexed as

DepressionHeart DiseasesMortalityAdultAgedCause of DeathFemaleHumansMaleMiddle AgedNutrition SurveysProspective StudiesUnited StatesDepression symptomMortalityProspective cohortU.S. population

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.